Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cystectomy × 90 days × Clear all

Phase

Phase 2 5 Phase NA 1 Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Carboplatin 107 pembrolizumab 105 Cisplatin 100 Paclitaxel 81 Gemcitabine 75 Specimen Handling 68 Magnetic Resonance Spectroscopy 65 Docetaxel 56 Pemetrexed 52 Dexamethasone 51 Cyclophosphamide 51 Capecitabine 51 Radiotherapy 48 Oxaliplatin 48 Doxorubicin 45 Bevacizumab 43 Rituximab 41 Radiation 39 Fluorouracil 39 durvalumab 38 Lenalidomide 37 Leucovorin 35 Vincristine 34 atezolizumab 30 Etoposide 27 130-nm albumin-bound paclitaxel 27 Letrozole 26 Irinotecan 26 Prednisone 25 Trastuzumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04960709 2025-12-19

VOLGA

AstraZeneca

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡